Back to search
Chagas Disease With Heart Failure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chagas Disease With Heart Failure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chagas Disease With Heart Failure trials you may qualify forThe purpose of this study is to evaluate the effect of sacubitril/valsartan 200 mg BID compared with enalapril 10 mg BID, in addition to conventional heart fail…
This study aims to evaluate the prognostic value of myocardial mechanics parameters, including global longitudinal strain (GLS) and mechanical dispersion (MD),…
Chagas disease is considered by the World Health Organization (WHO) as one of the most neglected tropical diseases in the world, having relevance in many Latin…
The main purpose of the study is to determine noninvasive markers of brain involvement in Chagas disease. In a subgroup of patients with high intensity transien…
The investigators hypothesize that pharmaceutical care may constitute an important tool for the clinical management of these patients by improving their complia…
Due to the lack of information in the literature about the role of cardiac rehabilitation on Chagas heart failure, the aim of the present study was to evaluate…
It is a randomized prospective controlled study of transcatheter renal denervation in patients with systolic heart failure secondary to Chagas' disease. The pur…
Chagas disease (CD) is the major cause of disability secondary to tropical diseases in young adults from Latin America. In this region 20 million people are cur…